What is Neuraxis, Inc.'s Market Cap?

Neuraxis, Inc.'s Market Cap is $92.9M, based on as-reported figures from SEC (XBRL) filings.

What is Neuraxis, Inc.'s Enterprise Value?

Neuraxis, Inc.'s Enterprise Value is $84.7M, based on as-reported figures from SEC (XBRL) filings.

What is Neuraxis, Inc.'s Price / Sales?

Neuraxis, Inc.'s Price / Sales is 17.5×, based on as-reported figures from SEC (XBRL) filings.

What is Neuraxis, Inc.'s EV / Revenue?

Neuraxis, Inc.'s EV / Revenue is 15.9×, based on as-reported figures from SEC (XBRL) filings.

What is Neuraxis, Inc.'s EV / EBITDA?

Neuraxis, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Neuraxis, Inc.'s Revenue (TTM)?

Neuraxis, Inc.'s Revenue (TTM) is $5.3M, based on as-reported figures from SEC (XBRL) filings.

What is Neuraxis, Inc.'s Net Income (TTM)?

Neuraxis, Inc.'s Net Income (TTM) is -$8.5M, based on as-reported figures from SEC (XBRL) filings.

What is Neuraxis, Inc.'s EBITDA?

Neuraxis, Inc.'s EBITDA is -$7.6M, based on as-reported figures from SEC (XBRL) filings.

What is Neuraxis, Inc.'s Diluted EPS (TTM)?

Neuraxis, Inc.'s Diluted EPS (TTM) is -0.67, based on as-reported figures from SEC (XBRL) filings.

What is Neuraxis, Inc.'s EBITDA Margin?

Neuraxis, Inc.'s EBITDA Margin is -143.1%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

Neuraxis, Inc.

XASE · usd

SIC 3845 · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

FIGI BBG01C9N1368

7.40▼ 0.20 (-2.63%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 7.60
Day's Range: 7.36 – 7.68
52-Week Range: 2.21 – 9.33
Volume: 75.2K
Avg Volume: 183.1K

Share Statistics

Shares Outstanding
Employees: 24
Exchange: XASE
Listed: 2023-08-09

Share count as of August 6, 2026

Neuraxis, Inc. (NRXS) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Neuraxis, Inc. (NRXS)

What is Neuraxis, Inc.'s Market Cap?: Neuraxis, Inc.'s Market Cap is $92.9M, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s Enterprise Value?: Neuraxis, Inc.'s Enterprise Value is $84.7M, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s Price / Sales?: Neuraxis, Inc.'s Price / Sales is 17.5×, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s EV / Revenue?: Neuraxis, Inc.'s EV / Revenue is 15.9×, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s EV / EBITDA?: Neuraxis, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s Revenue (TTM)?: Neuraxis, Inc.'s Revenue (TTM) is $5.3M, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s Net Income (TTM)?: Neuraxis, Inc.'s Net Income (TTM) is -$8.5M, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s EBITDA?: Neuraxis, Inc.'s EBITDA is -$7.6M, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s Diluted EPS (TTM)?: Neuraxis, Inc.'s Diluted EPS (TTM) is -0.67, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s EBITDA Margin?: Neuraxis, Inc.'s EBITDA Margin is -143.1%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · NRXSAs-filed SEC (XBRL) data